CCL11 and Bartsocas-Papas syndrome 1: When we combine two or more urinary biomarkers with a more than 70% sensitivity, specificity, PPV, and NPV in discriminating IC/BPS from all LUTD subgroups, combining a higher eotaxin (≥2.290 pg/mL) and a higher TNF-α (≥1.165 pg/mL) can provide a satisfactory diagnostic value for identifying IC/BPS from men with LUTD.